Tianjin Pharmaceutical Da Ren Tang ( SGX:T14) completed the disposal of a 12% stake in Tianjin TSKF Pharmaceutical to Haleon China and Haleon CH SARL, according to a late Friday filing with the Singapore Exchange.
Shares of the company were up over 2% in recent trading.
The disposal was completed after the company received the transfer price of around 1.62 billion yuan.